510(k) Report

510(k) · Cleared

Cleared

Amsino I.V. Administration Set, AMSAFE3 I.V Administration Set, Extension Sets

K093773510(k) SpecialCleared Mar 10, 201092-day reviewClass II21 CFR 880.5440

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Amsino International, Inc. · FPA Set, Administration, Intravascular

Cleared on Mar 10, 2010 as substantially equivalent to K973107 (Amsino Intl., Inc., 1997) after a 92-day review. Its family tree reaches back 1 generation to 1997. 2 later devices descend from it.

Decided
Mar 10, 2010
Review
92 days
Class
Class II
Product code
FPA
Recalls
None
Predicates
1

Its longest line of descent runs back 1 generation to K973107 (1997). 2 later devices descend from it, 1 citing it directly.

Descendants, by year cleared 2010: 1 descendant cleared2024: 1 descendant clearedK973107 · Amsino I.V. Administration Set · Amsino Intl., Inc. · 19971995200020052010201520202025
Descendants, by generation 1 generation forward: 1 descendant2 generations forward: 1 descendant K973107 · Amsino I.V. Administration Set · Amsino Intl., Inc. · 19970
  1. Root · 1 generation backK973107 Amsino I.V. Administration SetAmsino Intl., Inc. · 1997
  2. This deviceK093773 Amsino I.V. Administration Set, AMSAFE3 I.V Administration Set…Amsino International, Inc. · 2010
  3. Descendant · cites it directly · 1 of its ownK101958 Amsino I.V. Administration and Extension SetsAmsino International, Inc. · 2010
  4. Descendant · 2 generations on · 0 of its ownK222766 Disposable Extension SetShandong Ande Healthcare Apparatus Co., Ltd. · 2024

Most influential descendants

Showing 2 of 2 · See all
  • K101958Amsino I.V. Administration and Extension SetsAmsino International, Inc. · 2010 · cites it directly1descendant
  • K222766Disposable Extension SetShandong Ande Healthcare Apparatus Co., Ltd. · 2024 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−1K973107Amsino I.V. Administration SetAmsino Intl., Inc.1997—
0 (this device)K093773Amsino I.V. Administration Set, AMSAFE3 I.V Administration Set, Extension SetsAmsino International, Inc.2010—
+1K101958Amsino I.V. Administration and Extension SetsAmsino International, Inc.2010—
+2K222766Disposable Extension SetShandong Ande Healthcare Apparatus Co., Ltd.2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201010
202410
FIG. 1 — Lineage of K093773, 1997–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in FPA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new FPA device

  1. #1 K243841 Sparta Infusion Set for Insulinscore 13.4 · 3 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K973107Amsino I.V. Administration Set
Summary page 1
…SINQ International, Inc. hereby submits this Special 510(k): for AMSURE ® I V. Administration Set, a modification of our previously cleared AMSUPE®LV. ADMINISTRATIONSETt~k973107). We consider our intent to market this device as confidential commercial information and requests that it be treated as such by…
Amsino Intl., Inc.1997—

Also cleared against K973107: 3 other devices →

What descends from it? (2)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K101958Amsino I.V. Administration and Extension SetsAmsino International, Inc.20101

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Its one ancestor has no recall.
  • Of its descendants, K101958 (Amsino International, Inc., 2010) has gone furthest, with 1 descendant of its own.
  • 3 other devices also cite its predicate K973107.

How does its category compare?

All FPA devices

FPA Set, Administration, Intravascular: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · FPA

11in 2025

2007: 162008: 182009: 102010: 232011: 122012: 212013: 132014: 222015: 172016: 122017: 172018: 42019: 72020: 102021: 132022: 142023: 142024: 72025: 112026 (partial year): 5
2007high 23 (2010) · low 4 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · FPA

225in 2025

2007: 75 days median2008: 89 days median2009: 166 days median2010: 120 days median2011: 87 days median2012: 96 days median2013: 90 days median2014: 89 days median2015: 123 days median2016: 195 days median2017: 240 days median2018: 177 days median2019: 161 days median2020: 327 days median2021: 186 days median2022: 213 days median2023: 340 days median2024: 244 days median2025: 225 days median2026 (partial year): 266 days median
2007high 340 (2023) · low 75 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · FPA

98in 2025

2007: 172008: 152009: 1662010: 582011: 282012: 16, 4 Class I2013: 642014: 242015: 62016: 102017: 132018: 42019: 132020: 1072021: 12022: 9, 5 Class I2023: 12, 4 Class I2024: 13, 1 Class I2025: 98, 1 Class I2026 (partial year): 10, 2 Class I
2007high 166 (2009) · low 1 (2021)2026

Class I (17 since 2007) Class II/III not classified

Adverse event reports per year · FPA

34,506in 2025

2007: 1,4992008: 1,9412009: 2,5122010: 2,5372011: 4,4072012: 4,9302013: 4,6512014: 4,6952015: 6,6252016: 8,4702017: 6,4622018: 6,5742019: 11,2272020: 9,5632021: 10,4142022: 13,3932023: 10,9162024: 47,2102025: 34,506
2007high 47,210 (2024) · low 1,499 (2007)2025

MAUDE reports naming product code FPA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071675171,499
20081889151,941
2009101661662,512
201023120582,537
20111287284,407
2012219616 (4)4,930
20131390644,651
20142289244,695
20151712366,625
201612195108,470
201717240136,462
2018417746,574
201971611311,227
2020103271079,563
202113186110,414
2022142139 (5)13,393
20231434012 (4)10,916
2024724413 (1)47,210
20251122598 (1)34,506
2026526610 (2)—

What is it indicated for?

The AMSINO® I.V. ADMINISTRATION SET is a device intended to administer fluids from a container to a patient's vascular system through a catheter inserted into a vein.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K093773: Amsino I.V. Administration Set, AMSAFE3 I.V Administration Set, Extension Sets.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K093773

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026